(1) An employee, agent, or other individual must complete an anaphylaxis training program before using an epinephrine auto-injector. The training must be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment or by an individual or entity approved by the department of public health and environment. The department of public health and environment may approve specific entities or individuals to conduct training or may approve specific classes by individuals or entities. The training may be conducted online or in-person and, at a minimum, must cover:
How to recognize the signs and symptoms of severe allergic reactions, includinganaphylaxis;
The standards and procedures for the storage and administration of an epinephrineauto-injector; and
Emergency follow-up procedures.
(2) The individual or entity that conducts the anaphylaxis training program shall issue a certificate, on a form developed or approved by the department of public health and environment, to each person who successfully completes the anaphylaxis training program.
Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 630, § 1, effective May 14.
Reporting. An authorized entity that possesses and makes available epinephrine auto-injectors shall submit to the department of public health and environment, on a form developed by the department of public health and environment, a report of each incident on the authorized entity's premises that involves the administration of an epinephrine auto-injector pursuant to section 25-47-103. The department of public health and environment shall annually publish a report that summarizes and analyzes all reports submitted to it under this section.
Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 630, § 1, effective May 14.
Emergency public access stations - life-saving allergy medication. (1) Notwithstanding any law to the contrary:
A medical professional may prescribe a stock supply of epinephrine auto-injectors toany authorized entity for storage in an EPAS and may place a stock supply of epinephrine autoinjectors in an EPAS maintained by an authorized entity;
A medical professional may consult the user of an EPAS and make the epinephrineauto-injectors stored in the EPAS available to the user; and
Any person may use an EPAS to administer or provide an epinephrine auto-injectorto an individual believed in good faith to be experiencing anaphylaxis or to provide an epinephrine auto-injector to a family member, friend, colleague, caregiver, or person with a similar relationship with the individual.
(2) The use of an EPAS in accordance with this article is neither the practice of medicine nor of any other profession that requires licensure.
Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 630, § 1, effective May 14.